758 related articles for article (PubMed ID: 34997010)
1. Integrated bioinformatics and network pharmacology to identify the therapeutic target and molecular mechanisms of Huangqin decoction on ulcerative Colitis.
Wu Y; Liu X; Li G
Sci Rep; 2022 Jan; 12(1):159. PubMed ID: 34997010
[TBL] [Abstract][Full Text] [Related]
2. Effects of Huangqin Decoction on ulcerative colitis by targeting estrogen receptor alpha and ameliorating endothelial dysfunction based on system pharmacology.
Li MY; Li MX; Xu N; Li ZH; Zhang YM; Gan YX; Luo HJ; Zhou CL; Liu YH; Su ZR; Huang XQ; Zheng XB
J Ethnopharmacol; 2021 May; 271():113886. PubMed ID: 33524513
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the molecular mechanisms of Fuzi Lizhong Pill and Huangqin decoction in the treatment of the cold and heat syndromes of ulcerative colitis based on network pharmacology.
Hu X; Liu W; He M; Qiu Q; Zhou B; Liu R; Wu F; Huang Z
Comput Biol Med; 2023 Jun; 159():106870. PubMed ID: 37084637
[TBL] [Abstract][Full Text] [Related]
4. Based on Network Pharmacology to Explore the Molecular Targets and Mechanisms of Gegen Qinlian Decoction for the Treatment of Ulcerative Colitis.
Wei M; Li H; Li Q; Qiao Y; Ma Q; Xie R; Wang R; Liu Y; Wei C; Li B; Zheng C; Sun B; Yu B
Biomed Res Int; 2020; 2020():5217405. PubMed ID: 33299870
[TBL] [Abstract][Full Text] [Related]
5. Exploring the Mechanisms of Self-made Kuiyu Pingchang Recipe for the Treatment of Ulcerative Colitis and Irritable Bowel Syndrome using a Network Pharmacology-based Approach and Molecular Docking.
Wen Y; Wang X; Si K; Xu L; Huang S; Zhan Y
Curr Comput Aided Drug Des; 2024; 20(5):534-550. PubMed ID: 37190808
[TBL] [Abstract][Full Text] [Related]
6. Network pharmacology and molecular docking-based analyses to predict the potential mechanism of Huangqin decoction in treating colorectal cancer.
Li YJ; Tang DX; Yan HT; Yang B; Yang Z; Long FX
World J Clin Cases; 2023 Jul; 11(19):4553-4566. PubMed ID: 37469733
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the pharmacological mechanism of Banxia Xiexin decoction in treating depression and ulcerative colitis based on a biological network module.
Yu Y; Zhang G; Han T; Huang H
BMC Complement Med Ther; 2020 Jun; 20(1):199. PubMed ID: 32600331
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of Huangqin Decoction against ulcerative colitis and associated cancer in mice.
Chen G; Yang Y; Hu C; Cheng X; Xu Y; Cai X; Wang M; Yang CS; Cao P
Oncotarget; 2016 Sep; 7(38):61643-61655. PubMed ID: 27557503
[TBL] [Abstract][Full Text] [Related]
9. Study on the mechanism of Huangqin Decoction on rats with ulcerative colitis of damp-heat type base on mtDNA, TLR4, p-PI3K, p-Akt protein expression and microbiota.
Zheng Y; Liang C; Li Z; Chen J; Chen Z; Jiang Y; Dong Q; Xiao Y; Fu C; Liao W; Yuan X
J Ethnopharmacol; 2022 Sep; 295():115356. PubMed ID: 35568112
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota drives the attenuation of dextran sulphate sodium-induced colitis by Huangqin decoction.
Yang Y; Chen G; Yang Q; Ye J; Cai X; Tsering P; Cheng X; Hu C; Zhang S; Cao P
Oncotarget; 2017 Jul; 8(30):48863-48874. PubMed ID: 28415628
[TBL] [Abstract][Full Text] [Related]
11. Exploring the pharmacological components and effective mechanism of Mori Folium against periodontitis using network pharmacology and molecular docking.
Wu Z; Ji X; Shan C; Song J; Zhao J
Arch Oral Biol; 2022 Jul; 139():105391. PubMed ID: 35430443
[TBL] [Abstract][Full Text] [Related]
12. Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis.
Liu J; Liu J; Tong X; Peng W; Wei S; Sun T; Wang Y; Zhang B; Li W
Drug Des Devel Ther; 2021; 15():3255-3276. PubMed ID: 34349502
[TBL] [Abstract][Full Text] [Related]
13. Virtual screening of the multi-gene regulatory molecular mechanism of Si-Wu-tang against non-triple-negative breast cancer based on network pharmacology combined with experimental validation.
Zhang Z; Liu J; Liu Y; Shi D; He Y; Zhao P
J Ethnopharmacol; 2021 Apr; 269():113696. PubMed ID: 33358854
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of indigo naturalis on treating ulcerative colitis explored by GEO gene chips combined with network pharmacology and molecular docking.
Gu S; Xue Y; Gao Y; Shen S; Zhang Y; Chen K; Xue S; Pan J; Tang Y; Zhu H; Wu H; Dou D
Sci Rep; 2020 Sep; 10(1):15204. PubMed ID: 32938944
[TBL] [Abstract][Full Text] [Related]
15. Effect of Huangqin decoction on regulating intestinal flora in colitis mice characterized as inhibition of the NOD2-dependent pathway.
Huang S; He J; Chen Y; Wang X; Li Y; Su Y; Wen R; Li X; Yang G; Luo S; Zhou L; Luo X
Pharm Biol; 2022 Dec; 60(1):108-118. PubMed ID: 34967696
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of Huangjing Qianshi Decoction in treatment of prediabetes based on network pharmacology and molecular docking].
Cai JL; Li XP; Zhu YL; Deng GM; Yang L; Xia XH; Yi GQ; Chen XY
Zhongguo Zhong Yao Za Zhi; 2022 Feb; 47(4):1039-1050. PubMed ID: 35285205
[TBL] [Abstract][Full Text] [Related]
17. Huangqin decoction ameliorates DSS-induced ulcerative colitis: Role of gut microbiota and amino acid metabolism, mTOR pathway and intestinal epithelial barrier.
Li MX; Li MY; Lei JX; Wu YZ; Li ZH; Chen LM; Zhou CL; Su JY; Huang GX; Huang XQ; Zheng XB
Phytomedicine; 2022 Jun; 100():154052. PubMed ID: 35344714
[TBL] [Abstract][Full Text] [Related]
18. [Network pharmacological analysis and preliminary validation of mechanisms of Baitouweng Decoction in treatment of ulcerative colitis].
Miao ZW; Xu Y; Ning LQ; Yan J; Gu MJ; Ye B
Zhongguo Zhong Yao Za Zhi; 2020 Apr; 45(8):1808-1815. PubMed ID: 32489064
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism of Mahuang Lianqiao Chixiaodou Decoction in treating eczema by network pharmacology and molecular docking technology].
Zhang XW; Liu AM; Zhao JJ; Guo J; Chen XY; Qu XX
Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):894-901. PubMed ID: 33645094
[TBL] [Abstract][Full Text] [Related]
20. The Glabridin from Huangqin Decoction Prevents the Development of Ulcerative Colitis into Colitis-Associated Colorectal Cancer by Modulating MMP1/MMP3 Activity.
Li R; Chi H; Liao X; Cen S; Zou Y
Int Immunopharmacol; 2024 Jun; 135():112262. PubMed ID: 38805906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
